Can we truly define 'Fitness' for CAR-T therapy in large B cell lymphoma patients?

Chin Clin Oncol. 2024 Feb;13(1):15. doi: 10.21037/cco-23-78. Epub 2023 Oct 24.

Authors

Andy I Chen¹, Richard T Maziarz¹

Affiliation

¹ Oregon Health & Science University, Portland, OR, USA.

PMID: 37953244
DOI: 10.21037/cco-23-78

No abstract available

Keywords: Chimeric antigen receptor T cell (CAR-T); fitness; geriatric oncology; lymphoma.

MeSH terms

Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse* / drug therapy
Lymphoma, Large B-Cell, Diffuse* / pathology
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen